For a cash-pay patient, that translates to roughly $1,548/year on the Microdose tier, $2,148$2,748/year on Semaglutide Injection, and $2,748$3,708/year on Tirzepatide Injection well below FDA-approved branded GLP-1s at retail list price (~$1,000$1,350/month before insurance)
The STEP trials (20212023) established weekly dosing as the standard, showing 1522% body weight reduction over 68 weeks with excellent tolerability
[DOI] [PMC free article] [PubMed] [Google Scholar] 13.EAU Guidelines
J Clin Endocrinol Metab 96:853860 [DOI] [PubMed] [Google Scholar] 44.Mabilleau G, Mieczkowska A, Irwin N, Flatt PR, Chappard D (2013) Optimal bone mechanical and material properties require a functional glucagon-like peptide-1 receptor